Drug intelligence / Profile preview

cytidine monophosphate

Development stage
Phase 3
Lead developer
Ferrer
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Cytidine monophosphate (CMP) is a pyrimidine nucleotide that serves as a fundamental building block for RNA synthesis and a critical intermediate in the Kennedy pathway for phospholipid biosynthesis. Pharmacologically, CMP is primarily utilized as a neuroprotective and neuroregenerative agent, often administered in combination with other nucleotides (such as uridine monophosphate or triphosphate) and Vitamin B12. It acts as an anabolic precursor, providing essential substrates for the synthesis of structural phospholipids like phosphatidylcholine and sphingomyelin, which are vital components of neuronal membranes and the myelin sheath. By supporting the repair of damaged nerve fibers and enhancing axonal regeneration, CMP is investigated and used for various neuropathic conditions, including trigeminal neuralgia, low back pain, and surgical neurosensory disturbances.

Brand names
Nucleo CMP
Other names
5'-cytidylic acidCytidine 5'-monophosphatecytidylic acidCytidine-5'-monophosphoric acid
02

Targets

CMPK1 (Deoxycytidylate kinase)

Beyond the preview

Go deeper on cytidine monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cytidine monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call